In vivo, inhibition of ATM kinase by KU60019 has been reported as an effective radiosensitization strategy of orthotopic gliomas driven by the established U87 and U1242 cell lines bearing specific TP53 mutations17. The gene discussed is TP53; the disease is glioma.